Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit
Nautilus Biotechnology, Inc. (NASDAQ: NAUT) will participate in the virtual Capital One Spatial Biology & Proteomics Summit on September 28, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Nautilus Biotechnology, Inc. (NASDAQ: NAUT) will participate in the virtual Capital One Spatial Biology & Proteomics Summit on September 28, 2022. Co-founder and CEO Sujal Patel is set to take part in two panel discussions: "Proteomics 'Everything You Wanted to Know, But Were Afraid to Ask'" at 11:30 a.m. ET / 8:30 a.m. PT, and a CEO panel at 1:00 p.m. ET / 10 a.m. PT. Interested attendees can register by contacting kristen.patrick@capitalone.com.
Nautilus is dedicated to advancing proteomics with a platform technology aimed at enhancing human health.
Details
News Market Reaction – NAUT
The recorded move for NAUT in the trading session of this news was -3.38%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SEATTLE, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be participating in the upcoming Capital One Spatial Biology & Proteomics Summit taking place virtually on Wednesday, September 28, 2022.
Nautilus co-founder and CEO Sujal Patel is scheduled to participate in the following two executive panel discussions:
- Proteomics “Everything You Wanted to Know, But Were Afraid to Ask” at 11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time
- CEOs from Spatial Biology/Proteomics at 1:00 p.m. Eastern Time / 10 a.m. Pacific Time
Interested parties may contact kristen.patrick@capitalone.com to register to attend the virtual event.
About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle and its research and development headquarters in the San Francisco Bay Area, Nautilus is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.
Media Contact
press@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.